LENZ Therapeutics, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Other Events

Results of Operations and Financial Condition

Other Events

Regulation FD Disclosure

Other Events

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Other Events

2.02,9.01

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Notice of Effectiveness

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

FMR LLC

MILLENNIUM MANAGEMENT LLC

Thunen Shelley B

George Jeffrey P.

Guerard Frederic

Scheiner Zachary

MCCOLLUM JAMES W

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.; Kolchinsky Peter

Drapkin Kimberlee C

BlackRock, Inc.

Squarepoint Ops LLC

Chevallard Daniel R.

George Jeffrey P.

Schimmelpennink Evert B.

Ridgeback Capital Investments L.P.

FMR LLC

BlackRock, Inc.

Schimmelpennink Evert B.

Chevallard Daniel R.

Olsson Shawn

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)